BFM 89.9

HIGHLIGHTS 
Podcast  >  Marketplace  >  The Marketplace  >  Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)

Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)

Dr Jennifer Leong, Consultant Clinical Oncologist, Sunway Medical Center

28-Nov-22 15:45

Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)

Genetic testing technology has improved our ability to identify mutations in lung cancer, which may lead to more aggressive and rapidly worsening disease. In tandem with genetic testing, new drugs are also being discovered every day to target these rare mutations. Consultant clinical oncologist Dr Jennifer Leong gives us a glimpse into how genetic testing and targeted therapy is the new future for lung cancer.


This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  managing diseasemedical advances

Tags:  sunway medical centerlung cancer





Play / Pause

Listen now : The 6AM Stretch

Today’s Shows



6:00 AM

The 6AM Stretch

7:00 AM

World Market Watch

Tony Nash, CEO, Complete Intelligence

7:15 AM

Morning Brief

7:30 AM

Morning Brief

Adrian Chew, ASEAN AI and Data Leader, EY

7:45 AM

Morning Brief

Ahmad Maghfur Usman, Equity Analyst, Nomura Malaysia

8:00 AM

The Breakfast Grille

Manu Bhaskaran, Founding Partner & President, Centennial Asia Advisors

8:30 AM

Morning Brief

Dr. Rachel Gong, Deputy Director, Khazanah Research Institute

8:45 AM

Morning Brief

Dr Syaza Shukri, Associate Professor, International Islamic University of Malaysia (IIUM)

9:00 AM

Opening Bell

9:15 AM

Opening Bell

9:35 AM

What's the Focus

10:05 AM

Open For Business

Isaac Kon, CEO and Founder, Heytech Sdn Bhd

11:05 AM

Resource Centre

Matt Armitage, Founder, Kulturpop

12:00 PM

Enterprise Explores

Michael Freese, Professor of Management, Asia School of Business

1:00 PM

The Breakfast Grille Repeat

Manu Bhaskaran, Founding Partner & President, Centennial Asia Advisors

2:05 PM

Front Row

tbc

2:20 PM

Front Row

tbc

3:05 PM

Good Things

Native Allies; Daniel Teoh, Founder, Native

4:05 PM

Health & Living

Why A New TB Vaccine Is An Investment Worth Making; Dr Allison Portnoy, Assistant Professor of Global Health, Boston University School of Public Health

5:00 PM

The Evening Edition

7:05 PM

The Evening Edition

7:30 PM

Just For Kicks

9:00 PM

A Bit of Culture